Acute leukaemia, Acute lymphoblastic leukaemia (ALL), Acute myeloid leukaemia (AML), Brain (and spinal cord) tumours, Children's cancers, Leukaemia, Neuroblastoma, Sarcoma, Secondary cancers
Results
Phase 1/2
This trial was for children and young adults with cancer that had come back or continued to grow despite treatment.
It was for people more than 12 months and less than 25 years old, with one of the following cancers:
a type of brain tumour called high grade glioma
The trial was supported by Cancer Research UK. It was open for people to join between 2018 and 2022. Unfortunately the trial team weren’t able to get reliable results from the trial.
Recruitment start: 28 August 2018
Recruitment end: 31 July 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Francis Mussai
Cancer Research UK
University of Birmingham
Innovative Therapies for Children with Cancer in Europe (ITCC)
European Cancer Organisation Methods in Clinical Research workshop
Last reviewed: 23 Oct 2026
CRUK internal database number: 14953
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
